focus -WSS

focus

author：focus 2025-10-01 04:09:47 - browse：71145

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

WSS

PBM executives asked to testify by House panel

With fresh data, a dynamic duo powers Eli Lilly to new heights

The PBM ad wars are taking over Washington, D.C.

How corporate America is slashing DEI workers amid backlash to diversity programs

Novel spinal cord stimulator treats paralysis without surgery

How corporate America is slashing DEI workers amid backlash to diversity programs

Wikipedia

focus

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The effects of a landmark ruling on DNA ownership are becoming clearer

Medicare proposal to cover medical devices draws a mixed reaction

HHS's proposed rule does nothing to address the climate crisis

Jerome Adams on the need for new antivirals for Covid

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Is it ever OK for doctors to lie to their patients?

Virginia high school admissions case could be legal follow

Why Titanic fascinates society, still drawing tours to the wreckage

hotspot

Class action alleges UnitedHealth concealed DOJ probe

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Brain MRIs reveal impact of 'toxic stress' on Black children

Is it ever OK for doctors to lie to their patients?

Is it ever OK for doctors to lie to their patients?

Sen. Bill Cassidy on how to lower drug prices

explore

explore

focus

focus